Insight Molecular Diagnostics Inc.

IMDX ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2025

Total Assets: $25.8M

Liabilities Breakdown FY2025

Total Liabilities: $57.2M